Skip to main content
Header image
User picture
Groups: CATRIN, DOCTORAL STUDENT, IMTM, STAFF

Doctoral training

Molecular targets for innovative pharmaceutics

Specialization: Molecular and Translational Medicine
Status: Ongoing from 2023.

Journals

CBL-B – An upcoming immune-oncology target. Expert Opinion on Therapeutic Patents. 2024, ISSN: 1354-3776, PMID: 39582379,  PDF.